EDIT vs EG
Editas Medicine Inc (EDIT) versus Everest Group Ltd (EG) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported EG revenue for 2024-12-31 was $17.28B. Net income was $1.37B. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. EG currently screens at market cap $14.52B and trailing P/E 17.2.
EDIT currently screens at market cap $375.2M. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Not investment advice. Open the EDIT and EG stock pages for the full models.
Not investment advice.